Read More

Buxton Helmsley Issues Letter To EchoStar Directors Regarding Apparent Accounting And Securities Fraud, Apparent Fraudulent Conveyances, And Apparent Breaches Of Fiduciary Duty In Connection With DISH Merger

The Buxton Helmsley Group, Inc. (together with certain of its affiliates, "BHG" or "we"), the New York City-based investment fund manager with financial interests in EchoStar Corporation ("EchoStar" or the "Company")


Read More

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday’s Mid-Day Session

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.